产品
编 号：F112187
分子式：C172H263N43O52
分子量：3765.25
分子式：C172H263N43O52
分子量：3765.25
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
CAS No: 1295353-98-8
产品详情
生物活性：
Apraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.
体内研究：
Apraglutide (FE 203799; 5 mg/kg/dose, subcutaneously, twice on days 0 and 4 postsurgery) treated piglets are healthy, have significant lower fecal fat and energy losses and exhibite intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth on day 7.Animal Model:NewbornDuroc piglets, 2–5 days old and weighing between 2-2.6 kg.
Dosage:5 mg/kg/dose.
Administration:Subcutaneously, twice on days 0 and 4 postsurgery.
Result:On day 7, treated piglets were healthy, had significant lower fecal fat and energy losses and exhibited intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth.
Apraglutide (FE 203799), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.
体内研究：
Apraglutide (FE 203799; 5 mg/kg/dose, subcutaneously, twice on days 0 and 4 postsurgery) treated piglets are healthy, have significant lower fecal fat and energy losses and exhibite intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth on day 7.Animal Model:NewbornDuroc piglets, 2–5 days old and weighing between 2-2.6 kg.
Dosage:5 mg/kg/dose.
Administration:Subcutaneously, twice on days 0 and 4 postsurgery.
Result:On day 7, treated piglets were healthy, had significant lower fecal fat and energy losses and exhibited intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备